Neuroanesthesia & neurocritical care

Effect of Increasing Blood Pressure on Brain Tissue Oxygenation in Adults After Severe Traumatic Brain Injury*

Crit Care MedPublished Retrospective cohort study

Authors' conclusion

MAP augmentation after severe TBI resulted in four distinct PbtO 2 response patterns, including PbtO 2 improvement and cerebral hypoxia.

Study context

Population
Adults ≥18 years with severe traumatic brain injury (TBI) (admission GCS <9) with advanced neuromonitoring (ICP, PbtO2, cerebral autoregulation testing), level-I trauma centreMean arterial pressure (MAP) challenge tests ICU days 1–3
Participants
93 adults
Exposure
MAP augmentation with a vasopressor
Outcome
PbtO 2 response to MAP augmentation with a vasopressor
Methodological detailsretrospective review of prospectively collected data, single-centre
  • Retrospective review of prospectively collected data
  • Single-centre

Main finding

As reported in the abstract

PbtO2 response patterns to MAP augmentation
MAP increase across all 93 tests
25.7%
Cerebral perfusion pressure (CPP) increase
34.2%
PbtO2 increase
16.3%
No MAP or CPP correlation with PbtO2 (both R2)
0.00
Group 1: normal and maintained
58.5%
Group 2: normal and deteriorated (average 45.2% PbtO2 decrease)
2.2%
Group 3: low and improved (average 44% PbtO2 increase)
12.8%
Group 4: low and not improved
25.8%

Observational data: associations, not effects.

Further findings

ICP increase with MAP augmentation, impaired vs intact cerebral autoregulation

ICP increase, impaired vs intact autoregulation
8.9% vs. 3.8%, p = 0.06

ETCO2 increase and group 2 response

Average ETCO2 increase associated with group 2 when autoregulation impaired
5.9%, p = 0.02

Original publication

Effect of Increasing Blood Pressure on Brain Tissue Oxygenation in Adults After Severe Traumatic Brain Injury*. Crit Care Med. Published 1 February 2024. doi:10.1097/ccm.0000000000006211

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.